Atlas FDA

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

FDA device recall Z-0779-2017 · posted 2016-12-16 · Terminated

Recall details

Recalling firm
PerkinElmer Health Sciences, Inc.
Reason for recall
A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76 67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
Action taken
PerkinElmer initiated recall on November 16, 2016, delivered to the end customer by email facilitated through the PerkinElmer Technical Support group located in Akron Ohio. Technical Support will be asked to make sure the customers receive the Recall Letter and understand the recommended actions. Users asked to inspect inventory, discontinue use destroy the kits and complete the Response Forms and Destruction.Replacement kits will shipped.
Root cause
Other
Status
Terminated
Product code
CGJ
Quantity affected
79 kits
Distribution
CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
Date initiated
2016-11-16
Date posted
2016-12-16
Date terminated
2017-07-05
Location
Waltham, MA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
DELFIA (TM) HFSH KIT (K862043)Lkb Instruments, Inc.1986-06-24